Insights

Market commentary and guides

  • Resmed 1QFY17 – Get Ready to Buy

    Resmed (RMD.ASX) reports first quarter FY17 results on the 26th of October. The result is likely to meet or exceed market expectations. RMD is forecast to…

  • Caltex Continues to Perform

    We hold Caltex (CTX.ASX) across most client portfolios from lower price levels. The algorithm engines triggered the entry signal back on 8th of July when…

  • Take Profit on Boral and Buy James Hardie

    In today’s post we look at stocks recently commented on that require further attention, as profit taking is in sight or the entry level setups…

  • James Hardie – Buy Signal

    James Hardie (JHX.ASX) has now retraced back to $20.30 and our algorithm engines are flagging this as a buy signal. Strong EPS growth combined…

  • Resmed – Buying Opportunity

    Out of the three healthcare buy recommendations, (CSL, SHL and RMD),   made in the blog post back on 13th of September, CSL has increased 10% and SHL 10%+, however, RMD…

  • Oil Search – Price Bounces Following OPEC Agreement

    Oil Search (OSH.ASX) remains an attractive recovery story over the next few months with a potential price target back above $7.25. This target is seen…

  • Medibank – Is Value Emerging?

    Medibank (MPL.ASX) is now trading at a price level that warrants attention. The stock is forecast to pay a fully franked dividend in FY17…

  • ASX Mid-Week – Video Update

    I’ve decided this week to replace the usual multiple individual posts with a quick summary video. I think this does a better job of…

  • Global Macro

    The BoJ also announced that they would maintain its JPY 6 trillion a year purchases of equity exchange traded funds (ETFs), but widened the distribution…

  • XJO Index Watch – Key Levels you Should be Tracking

    Following last night’s decision in the US to leave rates unchanged, yield stocks will begin their recovery as we forecasted. See our list of…